<div id="readability-page-1"><div><p>Certain A Shares of Cofoe Medical Technology Co.,Ltd. are subject to a Lock-Up Agreement Ending on 26-OCT-2025. These A Shares will be under lockup for 1472 days starting from 15-OCT-2021 to 26-OCT-2025.</p><p>  Details:<br/> Holding shareholder Changsha Xiezihao Medical Investments Co., Ltd., actual controllers Zhang Min, Nie Juan and enterprise under control of actual controllers, Changsha Keyuan Tongchuang Enterprise Management Center (Limited Partnership) that within 36 months after the listing date, shall not transfer nor entrust to others for management direct or indirect shares in the company held prior to this issuance, nor allow the company to repurchase the said shares. If the closing price of the company?s share is lower than the issue price for 20 consecutive trading days within 6 months after listing, or if the closing price of the company?s share is lower than the issue price for the period ending six months after listing, then the lockup period shall automatically be extended for 6 months.</p><p>  Actual controllers, Zhang Min, Nie Juan, member of the board of directors, member of senior management with shareholding Zhang Zhiming that If the closing price of the company?s share is lower than the issue price for 20 consecutive trading days within 6 months after listing, or if the closing price of the company?s share is lower than the issue price for the period ending six months after listing, then the lockup period shall automatically be extended for 6 months and during the term of office as the company?s director, member of supervisory board, senior management personnel, the number of shares in the company transferred each year shall not exceed 25% of the total shares held in the company.</p><p>  Actual controllers Zhang Min, Nie Juan, member of the board of directors, member of senior management with shareholding, Zhang Zhiming, member of the board of directors with indirect shareholding Fang Shengshi and member of supervisory board with indirect shareholding Zhou Xiaojun that during the term of office as the company?s director, member of supervisory board, senior management personnel, the number of shares in the company transferred each year shall not exceed 25% of the total shares held in the company.</p><p>Member of the board of directors, member of senior management with shareholding Zhang Zhiming and Shareholders Ningbo Huaige Gongxin Equity Investment Partnership Enterprise (Limited Partnership); Guangzhou Danlu Venture Capital investment Fund Partnership Enterprise (LP); Xiangtan Chanxing Dingxin Private Equity Fund Enterprise (Limited Partnership); Hunan Cultural Tourism Investment Fund Enterprise (Limited Partnership); Changsha Yuhua Economic Development Dingxin Private Equity Fund Partnership Enterprise (Limited Partnership); Hunan Pofu Cultural Industry Investment Fund Enterprise (L.P.); Hunan Yanjin Puzi Holding Co., Ltd.; Hu Hongxia that within 12 months after the listing date, shall not transfer nor entrust to others for management direct or indirect shares in the company held prior to this issuance, nor allow the company to repurchase the said shares.</p></div></div>

可孚医疗

<p>可孚医疗科技有限公司的部分 A 股在锁定协议下，直到 2025 年 10 月 26 日，锁定期为 1472 天，从 2021 年 10 月 15 日开始。包括长沙谢子豪医疗投资有限公司及实际控制人张敏和聂娟在内的股东，无法转让在此次发行前持有的股份。如果在上市后 6 个月内，股价连续 20 个交易日低于发行价，锁定期将延长 6 个月。此外，董事和高级管理人员在任期内每年只能转让最多 25% 的股份</p>

可孚医疗科技股份有限公司的部分 A 股受到锁定协议的限制，该协议将于2025年10月26日到期